BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9153209)

  • 21. The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein.
    Liu CX; Li Y; Obermoeller-McCormick LM; Schwartz AL; Bu G
    J Biol Chem; 2001 Aug; 276(31):28889-96. PubMed ID: 11384978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity binding of receptor-associated protein to heparin and low density lipoprotein receptor-related protein requires similar basic amino acid sequence motifs.
    Melman L; Cao ZF; Rennke S; Marzolo MP; Wardell MR; Bu G
    J Biol Chem; 2001 Aug; 276(31):29338-46. PubMed ID: 11382778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding analysis of amino-terminal and carboxyl-terminal regions of the 39-kDa protein to the low density lipoprotein receptor-related protein.
    Warshawsky I; Bu G; Schwartz AL
    J Biol Chem; 1994 Feb; 269(5):3325-30. PubMed ID: 7508911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand binding properties of the very low density lipoprotein receptor. Absence of the third complement-type repeat encoded by exon 4 is associated with reduced binding of Mr 40,000 receptor-associated protein.
    Rettenberger PM; Oka K; Ellgaard L; Petersen HH; Christensen A; Martensen PM; Monard D; Etzerodt M; Chan L; Andreasen PA
    J Biol Chem; 1999 Mar; 274(13):8973-80. PubMed ID: 10085143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
    Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
    J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330.
    Kounnas MZ; Argraves WS; Strickland DK
    J Biol Chem; 1992 Oct; 267(29):21162-6. PubMed ID: 1400426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxin.
    Zdanovsky AG; Zdanovskaia MV; Strickland D; FitzGerald DJ
    J Biol Chem; 1996 Mar; 271(11):6122-8. PubMed ID: 8626399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissection of RAP-LRP interactions: binding of RAP and RAP fragments to complement-like repeats 7 and 8 from ligand binding cluster II of LRP.
    Lazic A; Dolmer K; Strickland DK; Gettins PG
    Arch Biochem Biophys; 2006 Jun; 450(2):167-75. PubMed ID: 16723114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
    Heegaard CW; Simonsen AC; Oka K; Kjøller L; Christensen A; Madsen B; Ellgaard L; Chan L; Andreasen PA
    J Biol Chem; 1995 Sep; 270(35):20855-61. PubMed ID: 7657671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissection of the domain architecture of the alpha2macroglobulin-receptor-associated protein.
    Ellgaard L; Holtet TL; Nielsen PR; Etzerodt M; Gliemann J; Thøgersen HC
    Eur J Biochem; 1997 Mar; 244(2):544-51. PubMed ID: 9119022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): consequences for the chaperone functions of RAP.
    Jensen JK; Dolmer K; Schar C; Gettins PG
    Biochem J; 2009 Jun; 421(2):273-82. PubMed ID: 19397492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
    Camani C; Gavin O; Kruithof EK
    Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric modulation of ligand binding to low density lipoprotein receptor-related protein by the receptor-associated protein requires critical lysine residues within its carboxyl-terminal domain.
    Migliorini MM; Behre EH; Brew S; Ingham KC; Strickland DK
    J Biol Chem; 2003 May; 278(20):17986-92. PubMed ID: 12637503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The carboxyl-terminal domain of receptor-associated protein facilitates proper folding and trafficking of the very low density lipoprotein receptor by interaction with the three amino-terminal ligand-binding repeats of the receptor.
    Savonen R; Obermoeller LM; Trausch-Azar JS; Schwartz AL; Bu G
    J Biol Chem; 1999 Sep; 274(36):25877-82. PubMed ID: 10464330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors.
    Willnow TE; Rohlmann A; Horton J; Otani H; Braun JR; Hammer RE; Herz J
    EMBO J; 1996 Jun; 15(11):2632-9. PubMed ID: 8654360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific binding of alpha-macroglobulin to complement-type repeat CR4 of the low-density lipoprotein receptor-related protein.
    Andersen OM; Christensen PA; Christensen LL; Jacobsen C; Moestrup SK; Etzerodt M; Thogersen HC
    Biochemistry; 2000 Sep; 39(35):10627-33. PubMed ID: 10978145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein.
    Obermoeller-McCormick LM; Li Y; Osaka H; FitzGerald DJ; Schwartz AL; Bu G
    J Cell Sci; 2001 Mar; 114(Pt 5):899-908. PubMed ID: 11181173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions.
    Mikhailenko I; Battey FD; Migliorini M; Ruiz JF; Argraves K; Moayeri M; Strickland DK
    J Biol Chem; 2001 Oct; 276(42):39484-91. PubMed ID: 11507091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors.
    Medh JD; Fry GL; Bowen SL; Pladet MW; Strickland DK; Chappell DA
    J Biol Chem; 1995 Jan; 270(2):536-40. PubMed ID: 7822276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.